引用本文: | 评价者: 王先明, 文献合成者: 肖瑜. BOLERO-2研究解读: 依维莫司联合依西美坦在激素受体阳性进展性乳腺癌的临床实践依据[J]. 循证医学, 2016, 16(3): 145-148. DOI: 10.12019/j.issn.1671-5144.2016.03.007 |
Citation: | Reviewer: WANG Xian-ming, Literature Co-worker: XIAO Yu. The Interpretation of BOLERO-2 Trial: Clinical Application Analysis on Everolimus Plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 145-148. DOI: 10.12019/j.issn.1671-5144.2016.03.007 |